Neuroinflammation mediated by the activated microglia is suggested to play a pivotal role in the pathogenesis of hypoxic brain injury; however, the underlying mechanism of microglia activation remains unclear. Here, we show that the canonical Notch signaling orchestrates microglia activation after hypoxic exposure which is closely associated with multiple pathological situations of the brain. Notch-1 and Delta-1 expression in primary microglia and BV-2 microglial cells was significantly elevated after hypoxia. Hypoxia-induced activation of Notch signaling was further confirmed by the concomitant increase in the expression and translocation of intracellular Notch receptor domain (NICD), together with RBPJk and target gene Hes-1 expression. Chemical inhibition of Notch signaling with N-[N-(3,5-difluorophenacetyl)-1-alany1-Sphenyglycine t-butyl ester (DAPT), a c-secretase inhibitor, effectively reduced hypoxia-induced upregulated expression of most inflammatory mediators. Notch inhibition also reduced NF-kB/p65 expression and translocation. Remarkably, Notch inhibition suppressed expression of TLR4/MyD88/TRAF6 pathways. In vivo, Notch signaling expression and activation in microglia were observed in the cerebrum of postnatal rats after hypoxic injury. Most interestingly, hypoxia-induced upregulation of NF-kB immunoexpression in microglia was prevented when the rats were given DAPT pretreatment underscoring the interrelationship between Notch signaling and NF-kB pathways. Taken together, we conclude that Notch signaling is involved in regulating microglia activation after hypoxia partly through the cross talk between TLR4/MyD88/ TRAF6/NF-kB pathways. Therefore, Notch signaling may serve as a prospective target for inhibition of microglia activation known to be implicated in brain damage in the developing brain.
Introduction
Notch signaling pathway is one of the most conserved pathways with versatility in function [1] [2] [3] . Mammalian canonical Notch signaling is activated when either the Delta or the Jagged ligands bind to one of four Notch receptors, thus resulting in a two-step proteolytic cleavage by the A Disintegrin And Metalloproteinase and c-secretase, which releases the intracellular Notch receptor domain (NICD) from the membrane [4] [5] [6] [7] . NICD then translocates to the nucleus, where it associates with the transcription factor Recombining binding protein suppressor of hairless (RBPJk) and other modulators to regulate a variety of cellular events, such as cell proliferation and differentiation [8, 9] .
In the central nervous system (CNS), the Notch signaling pathway is prominent among processes known to regulate normal development mainly on the neural progenitor cells, neurons, oligodendrocytes and astrocytes [10] [11] [12] [13] [14] . Recent evidence suggests that Notch may also play an important role in regulating the responsiveness of immune cells to stimulation and infection [15] [16] [17] [18] [19] . Microglia is one of the most important immune cells in the CNS and partakes in diverse roles within the CNS, namely normal brain development and inflammatory diseases. The involvement of the Notch signaling pathway in microglia has only recently been reported, suggesting a putative role in mediating microglial maturation and activation [15, [20] [21] [22] . We have reported in previous studies that Notch signaling modulates the expression of proinflammatory cytokines and nitric oxide (NO) in activated microglia after lipopolysaccharide (LPS) stimulation [15, 20] . These observations suggest that Notch activation in microglia is induced during CNS inflammation and may serve to regulate microglia function and pathophysiology of neuroinflammatory diseases.
It is well documented that hypoxia is linked to different neurodevelopmental diseases [23] [24] [25] [26] [27] [28] . In view of this, we have used in this study in vitro hypoxia models of both primary cultures of microglia and BV-2 cell line and an in vivo experimental rodent model with postnatal hypoxic exposure to investigate the role and mechanism of Notch signaling in neuroinflammation in the hypoxic developing brain. Although there are many Notch receptors and ligands that are all worthy of investigation, we have concentrated on the Notch-1 receptor and Notch ligand Delta-1 as we have found that Notch-1 was most significantly changed in our previous study investigating Notch signaling expression in microglia after LPS stimulation [20] . Hence, we felt it appropriate to concentrate on investigating Notch-1 expression in hypoxic microglia in this study. In addition, N-[N-(3,5-difluorophenacetyl)-1-alany1]-S-phenyglycine t-butyl ester (DAPT), a c-secretase inhibitor, which can efficiently block the c-secretase complex, was applied to investigate the response of the Notch inhibition.
Materials and Methods

Hypoxia treatment of postnatal rats
One-day-old postnatal rats (n = 10) were exposed to hypoxia by placing them in a chamber (Model MCO 18 M; SanyoBiomedical Electrical Co, Tokyo, Japan) filled with a gas mixture of 5% O 2 and 95% N 2 for 2 h. The rats were then allowed to recover under normoxic conditions for 3 and 7 d before sacrifice (n = 3 per time point); another group of 6 rats were kept outside the chamber and used as age-matched controls.
There was no differentiation between sexes and animals were randomized into control, and hypoxia groups. All hypoxic rats survived hypoxia treatment. The hypoxic rats were observed to suffer from severe cyanosis immediately after hypoxia and observed to recover after a few hours. Immediately after hypoxia, the rats were returned to their mother. Neonatal rats were accepted back by their mothers. No observable difference in size, body weight and general behaviour could be seen 3 days after hypoxia.
Postnatal rats (n = 3) were given a single intraperitoneal injection of DAPT (10 mg/kg Sigma-Aldrich, St. Louis, MO; Cat. No. D5942), a c-secretase inhibitor, 1 h before hypoxia to investigate the effect of Notch blockade in vivo [29, 30] . Control rats were subjected to hypoxia without DAPT pretreatment (n = 3).
The study was approved by the Institutional Animal Care and Use Committee, National University of Singapore (IACUC no: 095/08(A2)11). All efforts were made to reduce the number of rats used and their suffering.
Primary culture and hypoxia treatment of microglial cells
Twenty-five 3-day-old postnatal rats were used for the preparation of primary culture of microglia. Glial cells were isolated from the cerebrum of rat pups. Once confluent (12-14 days), microglia were isolated from the mixed glial population by a method previously described [31] . The purity of microglia was assessed by immunocytochemical labeling using OX42 (1:100, Santa Cruz Biotechnology, Santa Cruz, CA, USA; Cat. No. sc-53086), a specific marker of microglia. Microglial cultures with .96% purity were used for the study. For immunostaining, 2.0610 5 cells/well were plated in poly-L-lysine coated coverslips placed in 24-well plates. For hypoxia treatment, the culture medium was changed to fresh medium for routine culture before the cells were exposed to hypoxia by placing them in a chamber filled with a gas mixture of 3% O 2 /5% CO 2 /92% N 2 for 2, 4, 6, 12 and 24 h. To inhibit Notch signaling, microglia were pretreated with DAPT (Sigma-Aldrich, St. Louis, MO; Cat. No. D5942; DAPT dissolved in dimethyl sulfoxide) at 10 mM for 1 h and then exposed to hypoxia immediately. BV-2 cell culture and treatment BV-2 cells were used for in vitro study because our recent studies have shown that this microglial cell line responded swiftly to hypoxic exposure [32, 33] . The culture medium was changed prior to hypoxia exposure. Hypoxia was administered by placing the cells in a chamber filled with a gas mixture of 3% O 2 /5% CO 2 / 92% N 2 for 2, 4, 6, 8 and 12 h. DAPT (10 mM) was added into the medium 1 h before hypoxia treatment. Double immunofluorescence labeling in cerebrum, primary culture microglia and BV-2 cells Double immunofluorescence was carried out in postnatal rats to confirm the expression of Notch signaling in microglia as well as NF-kB activation after DAPT pretreatment. Briefly, neonatal rats were anaesthetized with 6% sodium pentobarbital administrated by intraperitoneal injection and perfused with a fixative containing 2% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4. The brains were then removed and placed in the same fixative for 4 h following which they were kept at 4uC overnight in 0.1 M phosphate buffer containing 15% sucrose. Coronal postnatal brain sections of 40 mm thickness were cut using a cryostat (Leica Microsystems Nussloch GmbH, Nussloch, Germany). The sections were incubated with NICD (goat anti rabbit 1:100, Merck KGaA, Darmstadt, Germany; Cat. No. 07-1232), Delta-1 (rabbit anti goat, 1:50, Santa Cruz Biotechnology, Santa Cruz, CA, USA; Cat. No. sc-8155) or NF-kB (rabbit anti goat, 1:100, Santa Cruz Biotechnology, Santa Cruz, CA, USA; Cat. No. sc-109) antibodies overnight at room temperature. After incubation, Cy3 conjugated secondary antibody was added and incubated at room temperature for 1 h. The sections were also incubated with FITC-conjugated lectin from tomato (Lycopersicon esculentum, 1:100, Sigma, MO, USA; Cat. No. L-0401) and mounted using a fluorescent mounting medium with DAPI (Sigma, MO, USA, Cat. No. F6057). Cellular localization was then examined and images captured under a confocal microscope (FV1000; Olympus, Tokyo, Japan). Both primary microglial cells and BV-2 cells were fixed with 4% paraformaldehyde for 20 min and processed as described above for localization of Notch-1, Delta-1 or NICD. All the samples in different groups were processed at the same time to ensure uniform development time across all slides for suitable comparison of staining intensity against the control. All pictures were taken with the same settings for exposure and contrast and have not been digitally enhanced.
Cell viability analysis of BV-2 and primary microglial cells at 37uC in a humidified atmosphere of 5% CO 2 and 95% air. Absorbance at 490 nm was measured using a microplate reader (GENIOS, Tecan, Switzerland). Cell viability is expressed as a percentage of control cells.
RT-PCR
Total RNA was extracted using the RNeasy Mini kit (Qiagen, Valencia, CA, USA; Cat. No. 74104). Reverse transcription reactions were performed using the AMV Reverse Transcriptase system (Promega, Madison, Wisconsin, USA) for BV-2 cells and SuperScriptH VILO TM cDNA Synthesis Kit (Invitrogen; Cat. No. 11754-050) for primary microglia. Primer pairs were designed using the primer design program (Primer 3 software version 1.0) and primer sequences for the genes and their corresponding amplicon size are listed in Table 1 . 2 ml aliquot of each reverse transcription product was added to the 10 ml reaction mixture containing Fast SYBRH Green Master Mix (Invitrogen, Cat. No. 4385612) and 0.5 mM of each primer to amplify the genes in a Fast Real-Time PCR machine (Biosystems 7900HT; Life Technologies biotechnology, Germany). The expression differences for genes between the control and treated cells were calculated by normalizing with the b-actin gene expression according to the following formula: -Fold change2
Western blotting analysis BV-2 cells were cultured and treated as described above. The cell pellets were collected and then the total proteins were extracted according to the manufacturer's instruction. Briefly, the cell pellets were collected by trypsinization. First, the cells were washed three times with 16phosphate-buffered saline followed by 16 trypsin-EDTA (Sigma; Cat. No. T4174) to dissociate the cells. The cells were then pooled and centrifuged at a speed of 1000 rpm for 5 mins. The supernatant was then discarded and the pellets washed twice with 16 phosphate-buffered saline. Protein concentration of samples was then determined by using a protein assay kit (Bio-Rad, Hercules, CA, USA; catalog No. 500-0002). Next, the protein samples were separated on 10% sodium dodecyl sulfatepolyacrylamide gels. The proteins embedded in the gel were then transferred to polyvinylidene difluoride membranes using a semidry electrophoretic transfer cell (Bio-Rad, Hercules, CA, USA). The membranes were incubated with Notch-1, NICD, RBP-Jk, Hes-1, TNF-a, IL-1b, NF-kB/p65, IL-10, M-CSF, TGFb1, MyD88, TRAF6 and b-actin overnight on a shaker at 4uC. The information of the different antibodies is listed in Table 2 . The membranes were incubated with horseradish peroxidaseconjugated secondary antibody (dilution 1:10000; Sigma-Aldrich, USA) for 1 h. The proteins were detected with a chemiluminescence detection system according to the manufacturer's instruction (Supersignal West Pico Horseradish Peroxidase Detection Kit; Pierce Biotechnology, IL, USA; Cat. No. 34077) and developed on film. The band intensity was quantified using Image J software (NIH). All experiments were repeated at least in triplicate.
Nitrite concentration measurement
BV-2 cells were exposed to hypoxia for 8 hours with or without DAPT as described above and the supernatant was collected. Nitric 
Phosphorylated-NF-kB p65 protein level analysis
After Notch inhibition with DAPT, the cell pellets were collected and the nuclear proteins in control and treated BV-2 cells were extracted. Nuclear proteins were extracted according to the manufacturer's instruction in the Nuclear Extraction Kit (Chemicon, Cat. No. 2900). Briefly, the cells are disrupted using the cytoplasmic lysis buffer. Next, the cell suspension was centrifuged and the cell pellet was re-suspended in two volumes of cytoplasmic lysis buffer. Nuclear protein was extracted by adding nuclear extraction buffer to the cell lysate to separate nuclear from cytosolic proteins. Upon centrifugation, the nuclear protein was extracted in the supernatant. The protein concentration was measured by Pierce TM BCA Protein Assay Kit (Pierce Biotechnology, Rockford, USA; Cat. No. 23227). Phospho-NFkB/p65 protein level analysis was carried out using PathScan Phospho-NF-kB/p65 (Ser536) Sandwich ELISA Kit (Cell signaling, CA, USA; Cat. No. 7173) according to the manufacturer's instruction.
Statistical analyses
The data are presented as mean 6SD. Statistical significance of differences between control and hypoxic groups was calculated using Student's t test and differences between control, hypoxic and treatment groups was calculated using one-way analysis of variance (ANOVA). Statistical significance in control vs hypoxic microglia was represented as *p,0.05 and **p,0.01; statistical significance in control vs control+DAPT group and hypoxia vs hypoxia+ DAPT group are represented as # p,0.05 and ## p,0.01.
Results
Notch signaling was activated in primary microglia and BV-2 cells after hypoxia
Primary microglia and BV-2 cells were subjected to hypoxia for 2-24 h and 2-12 h respectively. Notch-1 and Delta-1 mRNA expression in primary microglia was most significantly increased after hypoxia peaking at 4 h for Notch-1 and at 12 h for Delta-1 (Fig. 1A) . Expression of Notch-1 and Delta-1 in primary microglia was further confirmed by immunofluorescence staining which showed that the immunofluorescence intensity of Delta-1 and Notch-1 was obviously enhanced after hypoxia (Fig. 1B and C) . Notch signaling activation in primary microglia after hypoxia was confirmed by the detection of enhanced immunofluorescence intensity of NICD both in the cytoplasm and nucleus ( Fig. 2A) . RBP-Jk mRNA expression was progressively increased in primary microglia at various time points after hypoxia (Fig. 2B) . As the main target gene of Notch signaling, Hes-1 mRNA expression was concurrently increased at different time points after hypoxia, peaking at 12 h in which the increase was more than 9 folds compared with the control in primary microglia (Fig. 2B) . The expression and activation of Notch signaling was also observed in BV-2 cells (Fig. 3) . Delta-1 and Notch-1 mRNA expression was elevated being most significantly at 2 h after hypoxia (Fig. 3A) . Western blot analysis in BV-2 cells also showed that Notch-1 protein expression was progressively increased after hypoxic exposure (Fig. 3B) . NICD protein expression was increased especially at 6-8 h after hypoxia (Fig. 3B) , and protein expression of RBP-Jk also showed a significant increase being most pronounced at 8 h (Fig. 3B) . Increase in Hes-1 mRNA and protein expression after hypoxia was corroborated in hypoxic BV-2 cells (Fig. 3A and B) .
DAPT treatment inhibited Notch signaling activation in hypoxic microglia
DAPT was used to investigate the effect of Notch activation in microglial response. Notch inhibition by DAPT treatment was first confirmed both in primary microglia and BV-2 cells. There was no change in cell density and cell morphology as observed in primary microglia (Fig. 4A ) and BV-2 cells (data not shown) after hypoxia with or without DAPT pretreatment. No cytotoxic effect of DAPT was observed as investigated by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2h-tetrazolium, inner salt (data not shown). Both RBP-Jk and Hes-1 mRNA expressions were significantly inhibited in DAPT pretreated primary microglia after different durations of hypoxia (Fig. 4B) . In BV-2 cells, immunofluorescence staining showed a decrease in NICD immunofluorescence and nuclear translocation in Hypoxia +DAPT group compared with the Hypoxia group (Fig. 4C) . The decrease in Hes-1 protein expression was also observed in Hypoxia +DAPT group (Fig. 4D) . It is noteworthy that Notch-1 protein expression was increased significantly in DAPT pretreated hypoxic BV-2 cells compared with cells subjected to hypoxia exposure with DAPT treatment (Fig. 4D) .
Notch signaling blockade in microglia inhibited production of inflammatory mediators
As an increase in expression of inflammatory mediators is considered the hallmark feature of activated microglia, we next investigated whether Notch inhibition would affect the expression and secretion of inflammatory mediators by hypoxic microglia. It was found that hypoxia resulted in a significant increase in mRNA expression of TNF-a, IL-1b and iNOS in primary microglia which was partially inhibited following Notch signaling blockade (Fig. 5) . Similarly, western blot results showed a significant decrease in TNF-a, IL-1b and iNOS protein expression levels in hypoxic BV-2 cells pretreated with DAPT (Fig. 6A) .
We next investigated the expression of other inflammatory mediators, including M-CSF, IL-6, IL-10 and TGF-b1 in hypoxic primary microglia. Notch blockade showed a universal inhibition of the mRNA expression of M-CSF, IL-6, TGF-b1 and IL-10 (Fig. 5) . In parallel to the decrease in mRNA expression with Notch blockade, DAPT pretreatment also inhibited M-CSF and TGF-b1 protein expression in BV-2 cells across different groups with the exception of IL-10 whose expression was increased with DAPT pretreatment in BV-2 cells of control and after hypoxia for 8 h (Fig. 6B) . In addition, the increase in NO after hypoxia was significantly reduced with DAPT treatment in hypoxic BV-2 microglia (Fig. 6C) .
DAPT blockade of Notch signaling in hypoxic microglia decreased NF-kB pathway activation
We have reported previously that Notch-1 signaling could transactivate NF-kB/p65 as evidenced by the fact that NF-kB/ Figure 5 . Notch blockade altered the mRNA expression of inflammatory cytokines and iNOS induced by hypoxic stress in primary microglia. Reverse transcriptase (RT)-PCR analysis of TNF-a, IL-1b, iNOS, TGF-b1, M-CSF, IL-10 and IL-6 gene expression in primary microglia exposed to different duration of hypoxia with or without DAPT pretreatment. Note that mRNA expression of all the above mentioned genes is increased significantly to varying extents after hypoxic exposure for different duration. Significant difference between control vs hypoxia groups is shown as *p,0.05 and **p,0.01; significant difference between hypoxia vs hypoxia+DAPT groups is shown as p65 DNA binding ability was inhibited after Notch inhibition in LPS-activated microglia [34] . As NF-kB is an essential transcription factor for cytokines and iNOS expression in microglia, we investigated whether NF-kB pathway would be affected by Notch signaling in hypoxic microglia. Western blotting analysis indicated a significant increase in NF-kB/p65 in BV-2 cells exposed to hypoxia, but the increase was significantly prevented when the cells were pretreated with DAPT and exposed to hypoxia (Fig. 7A) . ELISA analysis showed that phospho-NF-kB/p65 protein expression in nucleus was increased by 1.5 fold following hypoxia, but the increase was inhibited in hypoxic BV-2 cells pretreated with DAPT (Fig. 7B) .
Notch blockade inhibited TLR4-Myd88-TAFR6 pathway that contributed to deactivation of NF-kB pathway in hypoxic microglia
As NF-kB phosphorylation and translocation induced by hypoxia was hindered by Notch inhibition, we next investigated whether this is due to an interference with upstream NF-kB signaling pathway via Toll like receptor 4 (TLR4) signaling through Myd88 and TRAF6. Activation of NF-kB signaling pathway in microglia has been reported to be mediated by many factors, the best recognized and characterized for this being the TLR4 after stimulation by its potent ligand LPS [35] [36] [37] . We previously reported that an increase in TLR4 expression can also mediate NF-kB signaling pathway activation in microglia after hypoxic exposure [33] . Activation of TLR4 has been reported to trigger a cascade of cellular signals that culminate in the activation of NF-kB which leads to inflammatory gene expression. Therefore, we investigated whether Notch signaling can interfere in the NF-kB activation via the TLR4-NF-kB pathway. Recent evidence also supports our hypothesis by suggesting that there exists an intricately linked crosstalk between Notch and Toll like receptor signaling pathways [15, 17, [38] [39] [40] . In this study, we found a significant inhibition of TLR4 mRNA expression in hypoxic primary microglia pretreated with DAPT (Fig. 8 A) .
TLR4 signaling activation in microglia after LPS stimulation triggers recruitment of the adaptor molecules, predominantly myeloid differentiation primary response 88 (MyD88) [41] , followed by interleukin-1 receptor-associated kinase and TNFR-associated factors (TRAF6). TRAF6 activates IkappaB kinase leading to the degradation of IkB, which frees NF-kB to translocate to the nucleus, where it binds to kB sites in the promoter region of genes encoding proinflammatory cytokines [42, 43] . By western blot analysis, we found a significant increase in MyD88 and TRAF6 protein expression after different durations of hypoxia (Fig. 8B) . This suggests that the MyD88 dependent pathway was activated in microglia after hypoxia exposure.
We next sought to determine whether DAPT blockade of Notch signaling would inhibit the expression of MyD88 and TRAF6. In primary microglia, a significant increase in both MyD88 and TRAF6 mRNA expression was observed after varying hypoxia exposure. In Hypoxia+ DAPT group, MyD88 and TRAF6 expression was substantially suppressed when compared with cells treated by hypoxia alone (Fig. 8C) . DAPT inhibition of MyD88 and TRAF6 protein expression was also found in BV-2 cells after hypoxic exposure (Fig. 8D) .
NICD expression in cerebral microglia after hypoxic exposure in postnatal rats
Arising from the in vitro results showing the roles of Notch signaling in microglia activation, we then extended our investigation to determine whether Notch signaling may play a role in microglia mediated inflammation in vivo. In the developing brain after hypoxic injury, Delta-1 immunoexpression was markedly increased on microglia in the corpus callosum (CC) and subventricular zone (SVZ) (Fig. 9) . To assess the activation of Notch signaling in microglia in the developing brain following a hypoxic injury, we further profiled the change of NICD expression in microglia in the CC. In vivo, NICD was noticeably increased in lectin-labeled microglia at 3 d and 7 d after hypoxia compared with the control (Fig. 10) .
DAPT pretreatment inhibited NF-kB activation in the microglia of postnatal rats subjected to hypoxia
In postnatal rats subjected to hypoxia, NF-kB immunofluorescence was markedly enhanced in hypoxic microglia cells when compared to cells in normal control rats. In rats given DAPT pretreatment, hypoxia-induced upregulation of NF-kB expression was noticeably reduced (Fig. 11) .
Discussion
Notch signaling expression and activation has been reported in a variety of cells and in different diseases yet its expression and function in microglia have remained elusive. Notch-1 signaling is most widely studied in immune cells including macrophages and microglia [20, 21, 39, 44, 45] . Recent studies by us have demonstrated the presence of Notch-1 signaling especially in activated microglia. We have shown that Notch signaling mediates inflammatory cytokine production in microglia challenged by LPS [20, 34] . As hypoxia is a common factor in many neuroinflammatory disorders, we sought to investigate the putative mechanism of Notch in hypoxia induced neuroinflammation in microglia. Here we provide evidence of a novel role for Notch signaling in regulating microglia activation in neuroinflammation which is linked to hypoxia. A major finding is the activation of canonical Notch signaling that regulates microglia activation after hypoxic exposure both in vitro and in vivo. Additionally, we have shown that Notch signaling-induced microglia activation is partially mediated by NF-kB via TLR4-MyD88-TRAF6 signaling.
The present results show that Delta-1 expression was increased in both primary microglia and BV-2 cells after hypoxia which differs from the decreased Delta-1 expression in LPS-stimulated BV2 cells [20] . The observed increase in Delta-1 expression was also replicated in vivo as reflected by the enhanced immunofluorescence intensity of Delta-1 in the SVZ and CC of postnatal rats following hypoxic exposure. Furthermore, activation of Notch-1 signaling was confirmed by the increase in NICD expression and an increase in expression of RBP-Jk, which works together to initiate the downstream pathway. Additionally, there was also a significant increase in Hes-1, the main target gene of Notch signaling in microglia after hypoxia. This is especially evident in the primary cultures of microglia in which Hes-1 increase was about 9 folds. This suggests the involvement of Hes-1 in microglia response after hypoxic exposure although the specific mechanism for this remains to be elucidated.
Notch signaling in various cell types has been reported to be activated under hypoxic conditions in vitro and in vivo in models of pathological conditions such as leukemia and cancer. In our study, we demonstrated the upregulation of Notch, Delta and RBP-Jk after hypoxia in BV-2 microglia cells. The mechanism via which hypoxia induces Notch signaling remains unclear although there have been suggested mechanisms, and whether these mechanisms are conserved across different cell types. For example, the upregulation of hypoxia-inducible factors (HIF) has been implicated in hypoxia-induced Notch signaling [46] which can be suppressed with the use of HIF inhibitor treatment [47] . Hypoxia may also activate Notch signaling by upregulating the expression of the Notch ligand Delta-like 4 in a positive feedback manner and also function to upregulate proteins that are dependent on Notchsignaling for a synergistic effect [48] . It is noteworthy that expression of both Notch receptor Notch-1 and ligand Delta-1 on microglia is increased after hypoxia suggesting that the Delta-1 ligands secreted may act through an autocrine as well as paracrine manner on the Notch receptors in view of the close proximity of microglial cells, which often exist in cell clusters. In neural stem cells, Notch signaling is activated on direct cell-to-cell contact as a result of interactions between Notch receptors and their ligands to regulate neural stem cell proliferation and differentiation. The expression of Notch receptors on microglia surrounding neural progenitor cells suggests that Notch ligands may act via a paracrine manner between microglia and neural stem cells. Furthermore, microglia is also capable of carrying out juxtacrine Notch signaling through direct cell-cell communication between Notch receptors of adjacent cells [49] . The binding between neighboring cells has been reported to assist in augmenting the receptor and ligand production, resulting in spatial patterning of longer range patterns through a positive feedback mechanism [50, 51] . This may prove beneficial in generating the observed coordinated increases in ligand, receptor and binding targets in our study in response to hypoxia.
Besides microglia, a few Delta-1-positive lectin-negative cells were also observed in the corpus callosum of neonatal rats. The identity of these cells remains unclear. However, as they were distributed in the white matter in which immature glial cells are known to preponderate, the upregulation and concomitant release of Delta-1 could function to promote Notch signaling in early oligodendrocytes and astrocytes. Notch signaling has been reported to play roles in oligodendrocyte precursor differentiation and negatively regulate neurogenesis through endolysosomal degradation in astrocytes [52] [53] [54] . Most commonly, Notch signaling is implicated in neural progenitor cells to regulate the transition between proliferation and neurogenesis [55] .
To further ascertain the functions of Notch signaling in microglia response after hypoxia, we applied a c-secretase inhibitor, namely DAPT which impaired NICD synthesis to block Notch signaling activation. Hes1 upregulation induced by hypoxia was inhibited in DAPT pretreated cells and the inhibition of csecretase activity by DAPT also resulted in the decrease in RBP-Jk mRNA expression, possibly through the effect of hypoxia-induced upregulation of Notch signaling. It is striking that blockade of Notch resulted in an almost universal inhibition of expression and production of several cytokines with the exception of IL-10. IL-10, which is generally considered as an anti-inflammatory factor was increased after DAPT treatment. DAPT inhibited IL-10 mRNA expression beginning at 4 h after hypoxia; however western blot analysis in BV-2 cells showed that DAPT increased IL-10 protein expression after 8 h of hypoxic exposure. IL-10 is generally considered as an anti-inflammatory factor during inflammation. Here we showed that IL-10 expression was suppressed by Notch signaling in microglia after hypoxic exposure. This observation suggests that Notch signaling activation not only induces the expression of pro-inflammatory factors, but also inhibits the expression and secretion of some anti-inflammatory factors. In addition, IL10 was reported to inhibit microglia production of TNF-a, IL-1b, NO, ROS and suppresses NF-kB activation [56] ; therefore, the increase in IL-10 after Notch signaling inhibition may also contribute to the inhibition of NF-kB activation.
However, the exact regulating mechanism of Notch signaling to IL-10 is obscure. It has been reported IL10 expression was mediated by MAPK and Akt pathway [57] ; however, whether Notch signaling acts directly on IL10 or through MAPK and Akt pathway remains to be investigated. Another feature worthy of note is the effect of Notch signaling on TGF-b1 expression in hypoxic microglia. A possible cross talk between Notch signaling and TGF-b1 pathway has been reported in adenocarcinomic human alveolar basal epithelial cells and rat hepatic stellate cells [29, 58] ; however, such crosstalk in microglia has not been reported and needs further investigation.
NF-kB is a transcription factor known to regulate genes of a spectrum of processes including inflammation. The canonical pathway is induced by most physiological NF-kB stimuli including signals emanating from cytokine receptors for example, TLR4. The canonical pathway mainly leads to phosphorylation of IkBa and nuclear translocation of mostly p65-containing heterodimers [59] . From the structure and the activated process of NF-kB pathway, it is not surprising that NF-kB activity is tightly controlled at multiple levels by positive and negative regulatory elements. Accumulating evidence supports the existence of important but poorly understood cross-talk between Notch and NF-kB pathway in many cells, including macrophage and microglia [15, 34, 59, 60] . In our previous study we have also demonstrated that Notch blockade can inhibit NF-kB gene binding activity in microglia after stimulation with LPS [34] . We show here that Notch blockade can inhibit NF-kB/p65 expression and translocation into the nucleus induced by hypoxia suggesting that Notch pathway enhances the release of NF-kB dimers that include NF-kB/p65. This has led us to hypothesize that some elements or factors which function in the release and translocation of NF-kB/p65 might have been affected after Notch signaling by DAPT. This notion is further supported by the significant decrease in TLR4, MyD88 and TRAF6 mRNA as well as MyD88 and TRAF6 protein expression after Notch inhibition in microglia following hypoxic exposure. This suggests that Notch signaling may mediate hypoxia induced TLR4 expression which subsequently activates the MyD88 and TRAF6 expression. Hence, Notch signaling blockade may act directly on MyD88 or TRAF6 as suggested in a study investigating Notch-TLR in macrophages [15] . The difference in Notch blockade may be due to the use of varying cell models and methodology. Nonetheless, the present results have shown that inhibition of Notch signaling may exert its influence through TRAF6 on NF-kB. However, as NF-kB activity is controlled at different levels by positive and negative regulatory elements, multiple targets may exist for the action of Notch signaling in NF-kB activity. In addition, HIF-1a has been reported to mediate TLR4-NF-kB expression in hypoxic microglia and interaction between HIF-1a and Notch signaling has been reported in many cell types [61, 62] . It was reported in human embryonic kidney 293T cells that NICD enhances recruitment of HIF-1a to its target promoters and depresses HIF-1a function by sequestering factor-inhibiting HIF-1a away from HIF-1a after hypoxia stress [62] . Therefore, we speculate that Notch signalling blockade by DAPT may also repress HIF-1a activity, thereby inhibiting the expression of downstream molecular signaling. Nevertheless, this hypothesis requires further investigation.
DAPT is a c-secretase inhibitor, which is a powerful blocker of Notch activity. Hence, the effect of DAPT inhibition e.g. on inflammation may be inferred as the effect of interfering with Notch intracellular part NICD synthesis. On the other hand, although c-secretase inhibitors may be a useful in screening for involvement of the Notch-signaling pathway, genetic approaches Figure 11 . DAPT pretreatment inhibited the increase in NF-kB immunoexpression in microglia of neonatal rats after hypoxic treatment. Confocal images showing the expression of NF-kB in lectinlabeled (green) microglia (arrows) in the corpus callosum of control (ac), hypoxia (d-f) and hypoxia +DAPT (g-i) rats at 24 h after hypoxic exposure. Increase in NF-kB expression in microglia of the corpus callosum was evident in hypoxic rats (e,f). In hypoxia +DAPT rats, increase in NF-kB was inhibited when compared with that in the hypoxic rats (h,i). Note lack of NF-kB expression in lectin positive blood vessels (arrowhead). Scale bar = 20 mm. doi:10.1371/journal.pone.0078439.g011 such as knockdown or over expression studies are necessary for more definitive conclusions regarding such involvement.
The present results derived from primary microglia and BV-2 cells subjected to hypoxic exposure in vitro have prompted us to extend our investigation to examine the expression and function of Notch signaling in activated microglia in a hypoxia animal model. The most striking feature was the activation of Notch signaling in the developing brain after hypoxic injury. Activation of Notch signaling in microglia of postnatal rats after hypoxia was followed by an increase in NICD expression in amoeboid microglial cells localized in the CC. The function of Notch signaling activation was confirmed by the fact that DAPT pretreatment significantly prevented NF-kB activation in microglia of postnatal rats after hypoxia exposure. Our findings are consistent with the literature that Notch-1 antisense mice exhibited significantly lower numbers of activated microglia and reduced proinflammatory cytokine expression in the ipsilateral ischemic cortices compared to nontransgenic mice. Microglial activation was also attenuated in Notch-1 antisense cultures and in nontransgenic cultures treated with c-secretase inhibitor, which blocks the proteolytic cleavage and activation of Notch [21] . Some studies, however, have reported an opposing role of Notch signaling pathway in the activation of microglia and in the control of inflammatory reactions in the CNS [22] . Notwithstanding, it is unequivocal from the present results as well as from others that Notch receptor and its ligands are constitutively expressed by microglia and that Notch signaling pathway is activated after hypoxia and is functional in regulating NF-kB during inflammatory response.
To summarize, this study has demonstrated the increase of Notch signaling in activated microglia. As microglia-mediated brain inflammation is a hallmark feature of neurodegenerative diseases and is a prominent sequel of many acute forms of brain injury, anti-inflammatory treatment may act to reduce neurodegeneration and brain injury. Our finding that Notch signaling can promote microglia activation presents a potential molecular target for the development of CNS anti-inflammatory drugs. However, considering that Notch signaling is expressed on a variety of cells including stem cells in the CNS, the use of Notch signaling inhibitors such as DAPT as a potential therapeutic agent in CNS disorders awaits further consideration.
